BioCentury | Aug 26, 2020
Deals
Aug. 25 Quick Takes: A slew of private financings led by Connect’s $115M series C; plus BMS-Forbius, Takeda deals, Bio-Thera-BeiGene and adds to HKSE, NASDAQ queues
...Pharmaceutical Co. Ltd.
Blackstone Group
Bio-Thera Solutions Ltd.
BeiGene Ltd.
Prelude Therapeutics Inc.
Silence Therapeutics plc
Sirnaomics Inc.
RNAimmune Inc.
Dyne Therapeutics Inc.
ReViral Ltd.
DiscGenics
Yidu Tech Inc....
